Loading data for FBLG — first visit, this takes a few seconds.
FibroBiologics Inc. (FBLG)
NasdaqCM: FBLG
· 실시간 가격 · USD
1.29
+0.10 (8.40%)
종가 기준: Aug 21, 2026, 8:00 PM
1.44
+0.00%
애프터마켓: 7:30 PM
주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.
FibroBiologics Inc.(FBLG) 주가, 분석 및 데이터
8.40% (1D)
데이터 없음
FBLG 소개
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease;...
전체 기업 정보어닝 서프라이즈
FibroBiologics가 Jul 31, 2026에 분기 실적을 발표했습니다:
- 매출 $0 예상치 하회 $0, 및 NaN% 전년 대비 성장.
- EPS -0.66 예상치 상회 0.27, 및 72.50% 전년 대비 성장.
